By Value Investing Toronto : As the short thesis on Herbalife ( HLF ) is coming to fruition, Usana ( USNA ) could very much be next. Like Herbalife, Usana sells commodity-like products at premium prices without any convincing reasons
Shares of USANA Health Sciences ( USNA +9.1% ) enjoy a nice pop in sympathy with China's relatively gentle tap on the wrist to Nu Skin . Consensus estimates for
Top 10 Gainers: MVIS +21% . NUS +19% . VSR +13% . USNA +12% . SPPR +11% . CREG +10% . TCL +8% . ASTC +8% . ICLD +8% . Top 10 Losers: ASTM -22% . MNGA -20% . IDRA -20
By Douglas Brooks : (Editor's Note: The footnotes in this article have been linked directly when able, but a complete review of all footnotes is available at the end of the article.) The announcement on March 12, 2014, that Herbalife Ltd. ( HLF ) had received a Civil Investigative Demand from the
By Bruce Craig : Is the Federal Trade Commission Stating its Current Enforcement Posture on MLMs? A recent article by Matt Stroud of the Verge raises the question whether the FTC may be setting the stage for further enhanced enforcement efforts in respect to Multi-Level Marketing: “But in a court
Graham. I found about 20 firms that make the grade; here’s a look at some of the best of the bunch. USANA Health Sciences ( USNA ) : Utah-based USANA ($440 million market cap) makes nutritional and personal care products that it sells
Steve Alexander submits: The Magic Formula Investing (MFI) strategy is a ranking system. Any particular universe of stocks can be ranked in the strategy's fashion - a composite of highest earnings yield and highest adjusted return on capital , both factors equally weighted. You can apply the ...
We are no longer providing equity research on Usana Health Sciences USNA . We provide broad coverage of more than 1,800 companies across 91 industry groups and adjust our coverage as necessary based on client demand and investor interest.
Usana Health Sciences ' USNA first-quarter results came in about where we expected, and we don't expect to alter our fair value estimate. Sales fell 4
On Monday, Usana Health Sciences USNA announced fourth-quarter and full-year earnings that were essentially in line with management's lowered guidance. Fourth